News Public wants pharma to reveal carbon footprint of drugs A survey has found that there is strong consumer support for pharma manufacturers to disclose the carbon footprint of their medicines, amid rising public scrutiny of the e
News Supporting the era of green pharmaceuticals in the UK According to a report by the Office of Health Economics (OHE), commissioned by the Association of th
Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face